000 01075 a2200265 4500
005 20250517195908.0
264 0 _c20190717
008 201907s 0 0 eng d
022 _a1527-7755
024 7 _a10.1200/JCO.2017.77.1899
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRuiz-Saenz, Ana
245 0 0 _aTargeting HER2 by Combination Therapies.
_h[electronic resource]
260 _bJournal of clinical oncology : official journal of the American Society of Clinical Oncology
_c03 2018
300 _a808-811 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aCombined Modality Therapy
_xmethods
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aReceptor, ErbB-2
_xmetabolism
700 1 _aMoasser, Mark M
773 0 _tJournal of clinical oncology : official journal of the American Society of Clinical Oncology
_gvol. 36
_gno. 8
_gp. 808-811
856 4 0 _uhttps://doi.org/10.1200/JCO.2017.77.1899
_zAvailable from publisher's website
999 _c28025303
_d28025303